Brain Zinc Deficiency Exacerbates Cognitive Decline in the R6/1 Model of Huntington’s Disease

There is currently no disease-modifying treatment for Huntington’s disease (HD), which is characterized by chorea motor impairment and cognitive decline. The zinc ionophore, PBT2, was previously shown to improve the phenotype of a HD mouse model and reported efficacy in certain cognitive tests in a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurotherapeutics
Asıl Yazarlar: Ayton, Scott, Lei, Peng, Appukuttan, Ambili T., Renoir, Thibault, Foliaki, Simote, Chen, Feng, Adlard, Paul A., Hannan, Anthony J., Bush, Ashley I.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2019
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007468/
https://ncbi.nlm.nih.gov/pubmed/31520307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-019-00785-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller